Skip to main content

Tweets

And now the paper that no one can find even if they are looking for it. On the relationship between disease activity and glucocorticoid disease. https://t.co/aT8I0jwQOJ@rheum_covid @ARD_BMJ https://t.co/7ntGLPdypJ
The COVID-19 Global Rheumatology Alliance @rheum_covid ( View Tweet )
2 days 2 hours ago
Dr. Robert Rosenberg, a founding physician of Arthritis and Rheumatism Associates, is retiring after 44 years effective 5/31/22. ARA extends our deepest gratitude and sincerest thanks for his decades of service and exceptional patient care. We wish him well in his retirement. https://t.co/mYQODUk5VY
Arth and Rheum Assoc @ARARheum ( View Tweet )
2 days 2 hours ago
At a time when most American doctors have never seen measles, I think we should stop calling things morbilliform.

Adam Cifu @adamcifu ( View Tweet )

2 days 2 hours ago
Differential diagnosis of dysphagia - when due to autoimmune dz is called Autoimmune neurogenic dysphagia - causes include inflammatory myopathies,inclusion body myositis, myasthenia gravis, Guillain–Barre, MS, NMO, paraneoplastic neuropathies https://t.co/oA0cPVJ5pJ https://t.co/58MyQwmxhL
Dr. John Cush @RheumNow ( View Tweet )
2 days 2 hours ago
⭐️Ethics of placebo-controlled trials in PsA ➡️move toward active comparator designs. Need to use measures of deeper response (e.g., ACR 50, PASI100). ⭐️Assesing safety: LTE studies not adequate. Use of phase 4 studies or observational data but beware confounding by indication

Rheum Cat @rheum_cat ( View Tweet )

2 days 2 hours ago
SARS-CoV-2-infected alveoli (specifically N protein-coding plasmid alone) induces IL-6 production. Also, COVID-19 Sera also induced IL-6, moreso in those w/ severe disease. anti-N Ab promotes IL-6 production & may lead to cytokine storm https://t.co/jfPNwZM0g8 https://t.co/FwIs11i2qc
Dr. John Cush @RheumNow ( View Tweet )
2 days 4 hours ago
Tonight!: Join us for Tuesday Night Rheumatology on Spondyloarthritis Spectrum. This webinar will feature lecture highlights followed by live audience Q & A. 7pm ET | Join on Zoom or watch LIVE on RheumNow Twitter, LinkedIn and Facebook.https://t.co/Y6MtCItIxw https://t.co/ysRM3cWyYa
Dr. John Cush @RheumNow ( View Tweet )
2 days 5 hours ago
Data from Scleroderma Lung Study (CTX vs MMF in PSS) shows that early progression of ILD by CXR scoring (≥ 2% at 12 or 24 months) experienced significantly worse long-term survival than those with stable Xrays (P = .014). https://t.co/BVy0WEE6G8 https://t.co/e6NN7nxNDt
Dr. John Cush @RheumNow ( View Tweet )
2 days 9 hours ago
24 week, Phase II RCT of baricitinib in 314 active #SLE patients showed significant reductions in levels of dsDNA, IgG, Sm & ACL Abs; but had no effect on C3/C4, RNP, SSA, SSB. Changes in dsDNA did not correlate with SRI-4 responses though.https://t.co/cF6rHbtvf9 https://t.co/zXnUImaLHF
Dr. John Cush @RheumNow ( View Tweet )
2 days 10 hours ago
FDA has approved baricitinib (Olumiant) for the Treatment of Certain Hospitalized Patients with COVID-19 who require supplemental O2, mechanical ventilation, ECMO. Rec dose: 4-mg once daily for 14 days or until hospital discharge https://t.co/RiEp01tc0v https://t.co/f3RvUAzdRp
Dr. John Cush @RheumNow ( View Tweet )
3 days 2 hours ago
Cool NEJM Case of Spinal Gout in 82-yr-old woman with 3-wk hx of severe LBP, rigors, anorexia, incomplete urination. Hx of PsA, CKD, CHF treated w/ Humira, HCQ, diuretics. Imaging tophi in spine, responded to steroids and allopurinol. https://t.co/JgH2bPsDeu https://t.co/RAPNxohe55
Dr. John Cush @RheumNow ( View Tweet )
3 days 4 hours ago
New podcast available on Methotrexate Monitoring. Download wherever you get your podcasts. Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.https://t.co/TQiUMdS4R0 https://t.co/vgejiV3hUl
Dr. John Cush @RheumNow ( View Tweet )
3 days 5 hours ago
×